Conversely, loss-of-function mutations in NOTCH1 (where it acts as a tumor suppressor) may lead to hyperactivation of the NF-κB signaling pathway, resulting in upregulated PD-L1 expression (40, 41). Here, NFKB1 is linked to neoplasm.